À portée de main

Un empêchement Répondre à une commande. Écrire à partir de, autour d’une bibliothèque, médiathèque – j’hésite souvent sur l’intitulé – quoi de plus simple me suis-je dit, et pourtant découvrir qu’il y a de la crainte. Qu’il y a un empêchement. Bibliothèque universitaire Lumière Lyon 2 de la rue Chevreul. Je visualise bien le bâtiment érigé vers les quais du Rhône où le fleuve poursuit son chemin d’indifférence malgré les promeneurs sur la rive. Le bâtiment, je le connais de l’extérieur. Je n’..

Assessment of diagnostic utility of multivariate diagnostic models in differential diagnosis of ovarian tumors

Introduction: Ovarian cancer (OC) diagnosis remains a clinical challenge due to lack of early symptoms and insufficient accuracy of the available diagnostic methods. The purpose of this study was to determine whether osteopontin could be useful in differential diagnosis of ovarian tumors.Material and methods: Serum samples from 92 patients qualified for surgical treatment due to ovarian mass were divided into 2 groups according to the histopathological result: OC including borderline ovarian tumors (n = 39) and benign ovarian tumors (BOTs) (n = 53). CA125, HE4 and osteopontin concentrations were measured in all patients. Areas under the receiver operating characteristic curves (AUC of ROC) were used to compare the discriminative ability of the univariate and multivariate diagnostic models.Results: The addition of osteopontin to ROMA significantly improved the diagnostic performance of the test in 3 of the 5 analyses: 1) in the OC vs BOT group (from AUC of 0.955 to 0.975), 2) in premenopausal women OC vs BOT (from AUC of 0.828 to 0.892) and 3) in the FIGO I-II stage OC vs BOT (from AUC of 0.865 to 0.895). It did not alter the diagnostic performance of multifactor tests in the group of postmenopausal women nor in OC FIGO III-IV stage group. Osteopontin was also thebest single marker to differentiate between early stage OC and BOTs (AUC of 0.863).Conclusions: Osteopontin improves the diagnostic performance of a multimarker OC diagnostic test and could be useful in differential diagnosis of ovarian tumors, especially in pre-menopausal women and for early stage OC

Tours et détours en bibliothèque. Carnet de voyage

Une bibliothèque pour faire quoi ? 19 écrivains et 1 plasticienne répondent, à leur manière – pour faire un tour, pour regarder un film, pour donner RDV, pour se mettre au chaud, pour lire, pour mettre le feu, pour parler de Flaubert, pour photographier le chantier, pour faire le ménage, pour être seul avec d'autres, pour travailler, pour dormir... Dans des styles différents, entre récits, nouvelles ou témoignages, les auteurs ont composé un portrait à multiples facettes de ce lieu public, et de ses passagers. Leurs textes reflètent aussi les grandes tendances de la littérature contemporaine, tournés pour certains vers le politique ou le social, pour d'autres vers le poétique ou le biographique. De son côté, en photographe, Aurélie Pétrel donne un ancrage visuel à ce Carnet de voyage

Tours et détours en bibliothèque. Carnet de voyage

Une bibliothèque pour faire quoi ? 19 écrivains et 1 plasticienne répondent, à leur manière – pour faire un tour, pour regarder un film, pour donner RDV, pour se mettre au chaud, pour lire, pour mettre le feu, pour parler de Flaubert, pour photographier le chantier, pour faire le ménage, pour être seul avec d\u27autres, pour travailler, pour dormir... Dans des styles différents, entre récits, nouvelles ou témoignages, les auteurs ont composé un portrait à multiples facettes de ce lieu public, et de ses passagers. Leurs textes reflètent aussi les grandes tendances de la littérature contemporaine, tournés pour certains vers le politique ou le social, pour d\u27autres vers le poétique ou le biographique. De son côté, en photographe, Aurélie Pétrel donne un ancrage visuel à ce Carnet de voyage

Understanding Ovarian Cancer: iTRAQ-Based Proteomics for Biomarker Discovery

Despite many years of studies, ovarian cancer remains one of the top ten cancers worldwide. Its high mortality rate is mainly due to lack of sufficient diagnostic methods. For this reason, our research focused on the identification of blood markers whose appearance would precede the clinical manifestation of the disease. ITRAQ-tagging (isobaric Tags for Relative and Absolute Quantification) coupled with mass spectrometry technology was applied. Three groups of samples derived from patients with: ovarian cancer, benign ovarian tumor, and healthy controls, were examined. Mass spectrometry analysis allowed for highlighting the dysregulation of several proteins associated with ovarian cancer. Further validation of the obtained results indicated that five proteins (Serotransferrin, Amyloid A1, Hemopexin, C-reactive protein, Albumin) were differentially expressed in ovarian cancer group. Interestingly, the addition of Albumin, Serotransferrin, and Amyloid A1 to CA125 (cancer antigen 125) and HE4 (human epididymis protein4) improved the diagnostic performance of the model discriminating between benign and malignant tumors. Identified proteins shed light on the molecular signaling pathways that are associated with ovarian cancer development and should be further investigated in future studies. Our findings indicate five proteins with a strong potential to use in a multimarker test for screening and detection of ovarian cancer

Wplyw jonow chromu i kadmu na wzrost wybranych grzybow glebowych

W warunkach laboratoryjnych oznaczono wpływ soli chromu i kadmu w stężeniach 5,0 mmol·dm⁻³, 0,5 mmol·dm⁻³ i 0,05 mmol·dm⁻³ oraz ich interakcji na wzrost grzybów glebowych. Wyniki badań dowodzą, że grzyby oznaczały się zróżnicowaną reakcją na jony metali ciężkich. Ich działanie istotnie zależało od gatunku grzyba, rodzaju związku i jego stężenia. Spośród dwóch badanych związków mniej toksyczny w odniesieniu do większości badanych grzybów okazał się K₂Cr₂O₇, ale zastosowany tylko w stężeniu 0,05 mmol·dm⁻³. Działanie jednoczesne dwóch badanych metali ciężkich na wzrost grzybów glebowych było bardziej toksyczne niż związków zastosowanych pojedynczo.The affects of chromium and cadmium salts at 5.0 mmol·dm⁻³, 0.5 mmol·dm⁻³ and 0.05 mmol·dm⁻³ concentrations as well as their interaction on the growth of soil fungi were investigated under laboratory conditions. Study results revealed various reactions of fungi towards heavy metal ions. Their effects significantly depended on fungus species, metal type and concentration. Among two tested compounds, K₂Cr₂O₇ appeared to be less toxic for most of studied fungi, but when applied at 0.05 mmol·dm⁻³ concentration only. Simultaneous influence of both tested heavy metals upon the growth of soil fungi appeared to be more toxic than that of the compounds applied separately

Mass spectrometry-based proteomics techniques and their application in ovarian cancer research

Abstract Ovarian cancer has emerged as one of the leading cause of gynecological malignancies. So far, the measurement of CA125 and HE4 concentrations in blood and transvaginal ultrasound examination are essential ovarian cancer diagnostic methods. However, their sensitivity and specificity are still not sufficient to detect disease at the early stage. Moreover, applied treatment may appear to be ineffective due to drug-resistance. Because of a high mortality rate of ovarian cancer, there is a pressing need to develop innovative strategies leading to a full understanding of complicated molecular pathways related to cancerogenesis. Recent studies have shown the great potential of clinical proteomics in the characterization of many diseases, including ovarian cancer. Therefore, in this review, we summarized achievements of proteomics in ovarian cancer management. Since the development of mass spectrometry has caused a breakthrough in systems biology, we decided to focus on studies based on this technique. According to PubMed engine, in the years 2008–2010 the number of studies concerning OC proteomics was increasing, and since 2010 it has reached a plateau. Proteomics as a rapidly evolving branch of science may be essential in novel biomarkers discovery, therapy decisions, progression predication, monitoring of drug response or resistance. Despite the fact that proteomics has many to offer, we also discussed some limitations occur in ovarian cancer studies. Main difficulties concern both complexity and heterogeneity of ovarian cancer and drawbacks of the mass spectrometry strategies. This review summarizes challenges, capabilities, and promises of the mass spectrometry-based proteomics techniques in ovarian cancer management

Rapid and Accurate Approach for Honeybee Pollen Analysis Using ED-XRF and FTIR Spectroscopy

Since honeybee pollen is considered a “perfectly complete food” and is characterized by many beneficial properties (anti-inflammatory, antioxidant, anti-bacterial, etc.), it has begun to be used for therapeutic purposes. Consequently, there is a high need to develop methods for controlling its composition. A thorough bee pollen analysis can be very informative regarding its safety for consumption, the variability of its composition, its biogeographical origin, or harvest date. Therefore, in this study, two reliable and non-destructive spectroscopy methods, i.e., ED-XRF and ATR–FTIR, are proposed as a fast approach to characterize bee pollen. The collected samples were derived from apiaries located in west-central Poland. Additionally, some commercially available samples were analyzed. The applied methodology was optimized and combined with sophisticated chemometric tools. Data derived from IR analyses were also subjected to two-dimensional correlation spectroscopy. The developed ED-XRF method allowed the reliable quantification of eight macro- and micro-nutrients, while organic components were characterized by IR spectroscopy. Principal component analysis, cluster analysis, and obtained synchronous and asynchronous maps allowed the study of component changes occurring dependently on the date and location of harvest. The proposed approach proved to be an excellent tool to monitor the variability of the inorganic and organic content of bee pollen

Diagnostic Value of Serum Angiogenesis Markers in Ovarian Cancer Using Multiplex Immunoassay

As cancer development involves pathological vessel formation, 16 angiogenesis markers were evaluated as potential ovarian cancer (OC) biomarkers. Blood samples collected from 172 patients were divided based on histopathological result: OC (n = 38), borderline ovarian tumours (n = 6), non-malignant ovarian tumours (n = 62), healthy controls (n = 50) and 16 patients were excluded. Sixteen angiogenesis markers were measured using BioPlex Pro Human Cancer Biomarker Panel 1 immunoassay. Additionally, concentrations of cancer antigen 125 (CA125) and human epididymis protein 4 (HE4) were measured in patients with adnexal masses using electrochemiluminescence immunoassay. In the comparison between OC vs. non-OC, osteopontin achieved the highest area under the curve (AUC) of 0.79 (sensitivity 69%, specificity 78%). Multimarker models based on four to six markers (basic fibroblast growth factor—FGF-basic, follistatin, hepatocyte growth factor—HGF, osteopontin, platelet-derived growth factor AB/BB—PDGF-AB/BB, leptin) demonstrated higher discriminatory ability (AUC 0.80–0.81) than a single marker (AUC 0.79). When comparing OC with benign ovarian tumours, six markers had statistically different expression (osteopontin, leptin, follistatin, PDGF-AB/BB, HGF, FGF-basic). Osteopontin was the best single angiogenesis marker (AUC 0.825, sensitivity 72%, specificity 82%). A three-marker panel consisting of osteopontin, CA125 and HE4 better discriminated the groups (AUC 0.958) than HE4 or CA125 alone (AUC 0.941 and 0.932, respectively). Osteopontin should be further investigated as a potential biomarker in OC screening and differential diagnosis of ovarian tumours. Adding osteopontin to a panel of already used biomarkers (CA125 and HE4) significantly improves differential diagnosis between malignant and benign ovarian tumours

Identification of Serum Peptidome Signatures of Non-Small Cell Lung Cancer

Due to high mortality rates of lung cancer, there is a need for identification of new, clinically useful markers, which improve detection of this tumor in early stage of disease. In the current study, serum peptide profiling was evaluated as a diagnostic tool for non-small cell lung cancer patients. The combination of the ZipTip technology with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) for the analysis of peptide pattern of cancer patients (n = 153) and control subjects (n = 63) was presented for the first time. Based on the observed significant differences between cancer patients and control subjects, the classification model was created, which allowed for accurate group discrimination. The model turned out to be robust enough to discriminate a new validation set of samples with satisfactory sensitivity and specificity. Two peptides from the diagnostic pattern for non-small cell lung cancer (NSCLC) were identified as fragments of C3 and fibrinogen α chain. Since ELISA test did not confirm significant differences in the expression of complement component C3, further study will involve a quantitative approach to prove clinical utility of the other proteins from the proposed multi-peptide cancer signature